FZD8 and prostate carcinoma: Specifically, they reported that the unusual expression of FZD8 in prostate cancer resulted in the hyperactivation of Wnt signaling by triggering a positive feedback loop of Wnt3A, a ligand of the canonical pathway that causes bone metastasis.